CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C31704 | BRD-K92432769 | BRD-K92432769 | -- | -- | -- | Details |
| C31705 | BRD-K92433763 | BRD-K92433763 | -- | -- | -- | Details |
| C31706 | BRD-K92433833 | BRD-K92433833 | -- | -- | -- | Details |
| C31707 | BRD-K92434623 | BRD-K92434623 | -- | -- | -- | Details |
| C31708 | BRD-K92434936 | BRD-K92434936 | -- | -- | -- | Details |
| C31709 | BRD-K92439079 | BRD-K92439079 | -- | -- | -- | Details |
| C31710 | BRD-K92439564 | BRD-K92439564 | -- | -- | -- | Details |
| C31711 | BRD-K92440102 | BRD-K92440102 | -- | -- | -- | Details |
| C31712 | BRD-K92441219 | BRD-K92441219 | -- | -- | -- | Details |
| C31713 | BRD-K92441787 | bexarotene | RXRA; RXRB; RXRG | Retinoid receptor agonist | -- | Details |
| C31714 | BRD-K92444813 | BRD-K92444813 | -- | -- | -- | Details |
| C31715 | BRD-K92446632 | BRD-K92446632 | -- | -- | -- | Details |
| C31716 | BRD-K92446736 | zatebradine | HCN4; HCN1; HCN3; HCN2 | HCN channel blocker | -- | Details |
| C31717 | BRD-K92455082 | BRD-K92455082 | -- | -- | -- | Details |
| C31718 | BRD-K92455228 | BRD-K92455228 | -- | -- | -- | Details |
| C31719 | BRD-K92456318 | BRD-K92456318 | -- | -- | -- | Details |
| C31720 | BRD-K92457070 | BRD-K92457070 | -- | -- | -- | Details |
| C31721 | BRD-K92458042 | BRD-K92458042 | -- | -- | -- | Details |
| C31722 | BRD-K92460921 | BRD-K92460921 | -- | -- | -- | Details |
| C31723 | BRD-K92462786 | BRD-K92462786 | -- | -- | -- | Details |
| C31724 | BRD-K92467929 | oxandrolone | AR | Androgen receptor agonist | -- | Details |
| C31725 | BRD-K92468187 | BRD-K92468187 | -- | -- | -- | Details |
| C31726 | BRD-K92470030 | BRD-K92470030 | -- | -- | -- | Details |
| C31727 | BRD-K92476250 | BRD-K92476250 | -- | -- | -- | Details |
| C31728 | BRD-K92479346 | BRD-K92479346 | -- | -- | -- | Details |
| C31729 | BRD-K92484282 | BRD-K92484282 | -- | -- | -- | Details |
| C31730 | BRD-K92489476 | BRD-K92489476 | -- | -- | -- | Details |
| C31731 | BRD-K92490248 | BRD-K92490248 | -- | -- | anethole-trithione | Details |
| C31732 | BRD-K92492521 | LY-255283 | -- | -- | -- | Details |
| C31733 | BRD-K92493271 | BRD-K92493271 | -- | -- | -- | Details |
| C31734 | BRD-K92498491 | BRD-K92498491 | -- | -- | -- | Details |
| C31735 | BRD-K92503225 | BRD-K92503225 | -- | -- | -- | Details |
| C31736 | BRD-K92513859 | BRD-K92513859 | -- | -- | -- | Details |
| C31737 | BRD-K92520489 | BRD-K92520489 | -- | -- | -- | Details |
| C31738 | BRD-K92522487 | BRD-K92522487 | -- | -- | -- | Details |
| C31739 | BRD-K92523103 | BRD-K92523103 | -- | -- | -- | Details |
| C31740 | BRD-K92524632 | BRD-K92524632 | -- | -- | -- | Details |
| C31741 | BRD-K92524823 | BRD-K92524823 | -- | -- | N-(1H-Benzoimidazol-2-yl)-benzene-1,2-diamine | Details |
| C31742 | BRD-K92541860 | BRD-K92541860 | -- | -- | -- | Details |
| C31743 | BRD-K92543914 | BRD-K92543914 | -- | -- | -- | Details |
| C31744 | BRD-K92544320 | BRD-K92544320 | -- | -- | -- | Details |
| C31745 | BRD-K92559570 | KU-C103884 | -- | -- | -- | Details |
| C31746 | BRD-K92565319 | BRD-K92565319 | -- | -- | -- | Details |
| C31747 | BRD-K92569554 | BRD-K92569554 | -- | -- | -- | Details |
| C31748 | BRD-K92570288 | BRD-K92570288 | -- | -- | -- | Details |
| C31749 | BRD-K92571446 | WZ-3105 | CLK2; CSNK1E; FLT3; ULK1 | CLK inhibitor | -- | Details |
| C31750 | BRD-K92573321 | BRD-K92573321 | -- | -- | -- | Details |
| C31751 | BRD-K92577649 | GBR-13069 | SLC6A3 | Dopamine uptake inhibitor | -- | Details |
| C31752 | BRD-K92579151 | BRD-K92579151 | -- | -- | -- | Details |
| C31753 | BRD-K92581247 | BRD-K92581247 | -- | -- | -- | Details |
| C31754 | BRD-K92593565 | BRD-K92593565 | -- | -- | -- | Details |
| C31755 | BRD-K92604082 | BRD-K92604082 | -- | -- | -- | Details |
| C31756 | BRD-K92607052 | BRD-K92607052 | -- | -- | -- | Details |
| C31757 | BRD-K92613113 | safinamide | MAOB; SLC6A3 | Glutamate inhibitor; Dopamine uptake inhibitor; Monoamine oxidase inhibitor | -- | Details |
| C31758 | BRD-K92613860 | BRD-K92613860 | -- | -- | -- | Details |
| C31759 | BRD-K92627732 | BRD-K92627732 | -- | -- | -- | Details |
| C31760 | BRD-K92632379 | BRD-K92632379 | -- | -- | -- | Details |
| C31761 | BRD-K92635027 | BRD-K92635027 | -- | -- | -- | Details |
| C31762 | BRD-K92636280 | BRD-K92636280 | -- | -- | -- | Details |
| C31763 | BRD-K92639644 | BRD-K92639644 | -- | -- | -- | Details |
| C31764 | BRD-K92640680 | BRD-K92640680 | -- | -- | -- | Details |
| C31765 | BRD-K92644009 | alfacalcidol | VDR | Vitamin D receptor agonist | -- | Details |
| C31766 | BRD-K92644013 | BRD-K92644013 | -- | -- | -- | Details |
| C31767 | BRD-K92646316 | BRD-K92646316 | -- | -- | -- | Details |
| C31768 | BRD-K92650579 | BRD-K92650579 | -- | -- | -- | Details |
| C31769 | BRD-K92650863 | BRD-K92650863 | -- | -- | -- | Details |
| C31770 | BRD-K92655427 | BRD-K92655427 | -- | -- | -- | Details |
| C31771 | BRD-K92655621 | BRD-K92655621 | -- | -- | -- | Details |
| C31772 | BRD-K92656786 | BRD-K92656786 | -- | -- | -- | Details |
| C31773 | BRD-K92657060 | zaleplon | GABRA1 | Benzodiazepine receptor agonist | -- | Details |
| C31774 | BRD-K92659561 | BRD-K92659561 | -- | -- | -- | Details |
| C31775 | BRD-K92659956 | BRD-K92659956 | -- | -- | -- | Details |
| C31776 | BRD-K92666980 | BRD-K92666980 | -- | -- | -- | Details |
| C31777 | BRD-K92678294 | irilin-a | -- | -- | -- | Details |
| C31778 | BRD-K92683369 | graveoline | -- | -- | -- | Details |
| C31779 | BRD-K92685052 | BRD-K92685052 | -- | -- | -- | Details |
| C31780 | BRD-K92700781 | BRD-K92700781 | -- | -- | -- | Details |
| C31781 | BRD-K92701606 | BRD-K92701606 | -- | -- | -- | Details |
| C31782 | BRD-K92707657 | BRD-K92707657 | -- | -- | -- | Details |
| C31783 | BRD-K92712225 | BRD-K92712225 | -- | -- | -- | Details |
| C31784 | BRD-K92712671 | BRD-K92712671 | -- | -- | -- | Details |
| C31785 | BRD-K92722247 | BRD-K92722247 | -- | -- | -- | Details |
| C31786 | BRD-K92723208 | BRD-K92723208 | -- | -- | -- | Details |
| C31787 | BRD-K92723993 | imatinib | CSF1R; ABL1; KIT; PDGFRA; PDGFRB; BCR | KIT inhibitor; PDGFR inhibitor; Abl kinase inhibitor | -- | Details |
| C31788 | BRD-K92725027 | BRD-K92725027 | -- | -- | -- | Details |
| C31789 | BRD-K92726801 | hydrastinine | -- | -- | -- | Details |
| C31790 | BRD-K92730269 | BRD-K92730269 | -- | -- | -- | Details |
| C31791 | BRD-K92731339 | perindopril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C31792 | BRD-K92732825 | BRD-K92732825 | -- | -- | -- | Details |
| C31793 | BRD-K92736140 | BRD-K92736140 | -- | -- | -- | Details |
| C31794 | BRD-K92740670 | BRD-K92740670 | -- | -- | -- | Details |
| C31795 | BRD-K92741883 | BRD-K92741883 | -- | -- | -- | Details |
| C31796 | BRD-K92742972 | BRD-K92742972 | -- | -- | -- | Details |
| C31797 | BRD-K92748025 | BRD-K92748025 | -- | -- | -- | Details |
| C31798 | BRD-K92749855 | BRD-K92749855 | -- | -- | -- | Details |
| C31799 | BRD-K92754162 | BRD-K92754162 | -- | -- | -- | Details |
| C31800 | BRD-K92754298 | BRD-K92754298 | -- | -- | -- | Details |
| C31801 | BRD-K92758126 | MD-920 | -- | -- | -- | Details |
| C31802 | BRD-K92758184 | BRD-K92758184 | -- | -- | -- | Details |
| C31803 | BRD-K92759025 | BRD-K92759025 | -- | -- | -- | Details |